DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin–sulfonylurea dual therapy with inadequate control

por Wong, Carlos K H, Man, Kenneth K C, Chan, Esther W Y, Wu, Tingting, Tse, Emily T Y, Wong, Ian C K, Lam, Cindy L K
Publicado 2020

Intensification with dipeptidyl peptidase-4 inhibitor, insulin, or thiazolidinediones and risks of all-cause mortality, cardiovascular diseases, and severe hypoglycemia in patients...

por Wong, Carlos K. H., Man, Kenneth K. C., Shi, Margaret, Chan, Esther W., Ho, Chu Wa, Tse, Emily T. Y., Wong, Ian C. K., Lam, Cindy L. K.
Publicado 2019